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Abstract 
Filamentous fungi encode distinct antifungal proteins (AFPs) that offer 
great potential to develop new antifungals. Fungi are considered immune to 
their own AFPs as occurs in Penicillium chrysogenum, the producer of the well-
known PAF. The Penicillium digitatum genome encodes only one afp gene 
(afpB), and the corresponding protein (AfpB) belongs to the class B 
phylogenetic cluster. Previous attempts to detect AfpB were not successful. In 
this work, immunodetection confirmed the absence of AfpB accumulation in wild 
type and previous recombinant constitutive P. digitatum strains. 
Biotechnological production and secretion of AfpB were achieved in P. digitatum 
with the use of a P. chrysogenum-based expression cassette and in the yeast 
Pichia pastoris with the α-factor signal peptide. Both strategies allowed proper 
protein folding, efficient production and single-step purification of AfpB from 
culture supernatants. AfpB showed antifungal activity higher than the 
P. chrysogenum PAF against the majority of the fungi tested, especially against 
Penicillium species and including P. digitatum, which was highly sensitive to the 
self-AfpB. Spectroscopic data suggest that native folding is not required for 
activity. AfpB also showed notable ability to withstand protease and thermal 
degradation and no haemolytic activity, making AfpB a promising candidate for 
the control of pathogenic fungi. 
 
Keywords: antifungal protein (AFP); AfpB; Penicillium digitatum; Penicillium 
chrysogenum; Pichia pastoris; fungal cell factory; phytopathogenic fungi. 
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Introduction 
Nowadays fungal infections have become a serious threat to human 
health and food security. Human fungal infections have severe consequences 
on the growing number of immune-compromised patients with high mortality 
rates. In addition, the control of plant diseases caused by phytopathogenic fungi 
represents a big challenge in agriculture. The emergence of antifungal resistant 
strains is in continuous growth, emphasizing the urgent need for the 
development of novel antifungal agents with properties and mechanisms of 
action different from existing ones1. 
Antifungal proteins (AFPs) secreted by filamentous fungi have been 
considered promising candidates for the development of novel antifungal 
compounds and therapies. AFPs are small, highly stable, cationic, cysteine-rich 
proteins (CRPs) stabilized by up to four disulphide bridges2. They are usually 
secreted in high amounts by filamentous Ascomycetes, mainly from the genera 
Penicillium and Aspergillus, and show potent antifungal activity against non-self 
fungi at micromolar concentrations. 
It is increasingly clear that fungi have a complex repertoire of AFPs that 
offers a great potential to obtain new antifungal agents. In a previous study, 
fungal genome sequences were searched to identify AFP-like sequences and 
conduct detailed phylogenetic studies3. Based on phylogenetic clustering but 
also on sequence alignment, cysteine pattern, intron position and Pfam domain 
identification, we proposed the classification of fungal AFPs into three classes: 
A, B and C3, expanding the two previously reported ones that divided the fungal 
AFPs into two clusters4,5. Recently, a fourth and distantly related group of AFPs 
has been described6. The fungal genomes that encode more than one AFP 
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include those from Penicillium chrysogenum and Penicillium expansum, which 
have one AFP belonging to each of three different classes3. In the case of the 
three P. chrysogenum AFPs (class A PAF, class B PgAfp and class C Pc-
Arctin) their antifungal activity has been experimentally demonstrated7-9. 
Another representative of the Penicillium genus is the citrus postharvest 
pathogen Penicillium digitatum, a necrotrophic filamentous fungus that is highly 
specific for citrus fruits and produces very important economic losses 
worldwide10,11. The recent sequencing of its genome allowed the identification of 
several potential AFP-like proteins10, although further phylogenetic analyses 
confirmed the presence of only one afp gene (afpB) whose corresponding 
protein has been classified into class B and was called AfpB3. 
The most characterized AFPs belong to class A: the AFP produced by 
Aspergillus giganteus12-15, PAF from P. chrysogenum16-19, and NFAP from 
Neosartorya fischeri20,21. Unfortunately, P. digitatum AfpB has not been 
experimentally characterized so far due to the lack of protein detection in 
P. digitatum cultures even in constitutive expression strains that produce up to 
1,000 times more afpB mRNA than the wild-type strain3. In any case, the 
tertiary structure of the putative AfpB was predicted by in silico molecular 
modelling, which allowed the identification of antifungal peptides based on the 
AfpB primary sequence and structure22. 
There is a need for low cost and effective AFP-production platforms to 
produce these proteins at the scale and purity required for their different 
applications as new antifungal drugs. In this context, the Pichia pastoris 
expression system was applied to produce active recombinant A. giganteus 
AFP23, P. chrysogenum PAF and PAF mutants16 and N. fischeri NFAP and 
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NFAP mutants24,25. Recently, a P. chrysogenum-based expression system for 
the production of AFPs was described, showing the feasibility of this approach 
for the overexpression of high amounts of PAF, PAF variants and NFAP18,19. 
The P. chrysogenum expression cassette consisted of the strong paf gene 
promoter, the paf pre-pro sequence (SP-pro sequence) for correct protein 
processing and secretion, and the paf gene terminator8. Moreover, this 
expression system was extended to heterologously express PAF in P. digitatum 
with similar yields to those obtained in P. chrysogenum, demonstrating the 
versatility of the system19. 
In this study, we have produced the protein AfpB from P. digitatum for the 
first time using two different expression systems: i) homologous expression in 
P. digitatum, using the P. chrysogenum-based expression cassette containing 
the paf gene promoter and terminator sequences, and either the paf or the 
native afpB SP-pro sequence, and ii) heterologous expression in P. pastoris, 
using an inducible promoter and the yeast α-factor signal peptide sequence (α-
factor SS). Recombinant AfpB has been successfully purified to homogeneity 
and structurally and functionally characterized. 
 
Results 
Recombinant production of AfpB in P. digitatum and P. pastoris. We used 
the P. chrysogenum-based expression cassette19 to express AfpB in 
P. digitatum under the regulation of the strong paf promoter and terminator 
sequences (Fig. 1). In our previous work, the presence of the paf SP-pro 
sequence warranted the secretion of PAF, PAF variants and NFAP proteins into 
the supernatant independently of the Penicillium species used as cell factory. 
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Here, in order to study the functionality of the native SP-pro sequence of the 
AfpB protein, two different transformation vectors with two expression cassettes 
for the afpB gene insertion in P. digitatum were constructed. Both constructions 
included the paf promoter and terminator sequences. However, in the first gene 
construction, the full-length afpB coding sequence (afpB) was cloned, while the 
second approach included the in silico predicted mature afpB coding sequence 
(afpB*) fused to the paf SP-pro sequence (Fig 1a). After evaluation of positive 
transformants for protein production, one clone with the highest production of 
the recombinant AfpB protein for each construction was selected for further 
characterization. The selected producer strains were PDSG2441 for AfpB and 
PDSG3543 for AfpB*. The genetic modification of these strains was confirmed 
molecularly (Supplementary Fig. S1) 
The growth of the selected transformant strains in solid medium is shown 
in Fig. 2. Since the P. chrysogenum PAF was already expressed in 
P. digitatum19, the PAF transformant strain (PDSG1521) was chosen as internal 
control in this study. AfpB transformants showed a moderate reduction of colony 
diameter on potato dextrose agar (PDA) plates (Fig. 2a,b), higher for the AfpB 
(PDSG2441) than for the AfpB* (PDSG3543) strain. However, the growth was 
indistinguishable from that of the parental strain in P. digitatum minimal medium 
(PdMM) (Fig. 2b). The PAF transformant did not show different phenotype to 
the parental strain in both media. The moderate reduction of growth shown in 
PDA plates for the transformants AfpB and AfpB* did not result in a difference in 
their pathogenicity and virulence shown during orange fruit infection 
(Supplementary Fig. S2). 
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Heterologous production of AfpB* was also addressed in P. pastoris. The 
genetic construct was designed for its gene inducible expression (AOX1 
promoter) and secretion of the corresponding protein (PpAfpB*, for AfpB* 
produced in P. pastoris) to the extracellular medium (Fig. 1b). With this 
purpose, afpB* cDNA was fused in frame to a shortened yeast α-factor SS, in 
which the Ste13 protease cleavage site was removed and the Kex2 protease 
cleavage site maintained. This modification was introduced to avoid the Ste13 
partial cleavage of the secretion signal resulting in the accumulation of an 
inactive protein, as previously reported for the AFP from A. giganteous23. The 
resulting construct was used to transform P. pastoris cells, and two independent 
transformant were selected for PpAfpB* production. 
 
Single-step cationic exchange chromatography allowed AfpB purification 
from P. digitatum and P. pastoris culture supernatants. Selected clones for 
AfpB production in P. digitatum were grown in PdMM and, after clearing the 
culture broth from insoluble matter, the proteins in the supernatant were purified 
by one-step cation-exchange chromatography. Optimal production was 
achieved after 11 days of growth, and the protein amounts varied between 12 
(AfpB) and 20 (AfpB*) mg/l. Both proteins eluted as a single chromatography 
peak at 0.25 M NaCl, and SDS-PAGE analysis revealed a single-protein band 
in both, having the same apparent molecular mass of approximately 6 kDa in 
agreement with the AfpB predicted molecular mass (6.46 kDa) (Fig. 3a, top 
panel). When comparing with the slightly smaller PAF (6.2 kDa), AfpB showed 
faster migration than expected. Anomalous migration in SDS-PAGE was also 
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observed for NFAP19, PgAFP9 and other fungal AFPs5 and seems to be related 
to the extreme isoelectric points of these proteins26. 
Two independent P. pastoris colonies were assayed to evaluate the 
PpAfpB* accumulation upon methanol induction at different time points. A 
polypeptide showing similar electrophoretic mobility to the AfpB produced in P. 
digitatum was observed in the supernatant of P. pastoris cells harbouring afpB* 
cDNA construct and grown under inducing conditions (Fig. 3b, top panel). The 
intensity of this band increased with time, reaching maximum levels at 48 hours 
of growth in methanol medium with strong aeration. This band was absent in the 
supernatant of cells grown under non-inducing conditions, as well as in cells 
transformed with the empty vector. It was not detected in the lysates of induced 
cells either, demonstrating its efficient secretion to the extracellular medium. 
The best producer colony was used to purify the secreted recombinant protein 
at large scale. The PpAfpB* was also easily purified to homogeneity by one-
step cation-exchange chromatography (Fig. 3b, top panel) with yields of 1.2-1.4 
mg/l. 
 
Immunodetection confirmed the absence of AfpB in the parental strain. 
Western blot analyses of 11-days old P. digitatum culture supernatants of 
different fungal strains and purified AfpB proteins were performed with 
antibodies against P. chrysogenum PAF27 and PAFB. PAFB is a protein from 
P. chrysogenum that is 88% identical to AfpB, and from which an antiserum was 
raised (unpublished). Culture supernatants of PDMG122 (null ∆afpB) and 
PDMG152 (constitutive afpBC) were also included in the analyses as controls 
and to confirm previous absence of detection by Coomasie Blue staining3. 
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Results indicated that both AfpB proteins and the corresponding supernatants 
reacted with anti-PAFB antibody (Fig. 2a, middle panel) while only purified PAF 
and the corresponding transformant strain PDSG1521 supernatant reacted with 
PAF antiserum (Fig. 2a, bottom panel). As expected, no protein band in the 
supernatant of the previous null transformant strain (∆afpB) reacted with the 
anti-PAFB antibody. Remarkably, no immunoreaction was observed in the 
culture supernatant of either the parental strain (CECT 20796) or the 
constitutive afpBc transformant strain (PDMG152), fully demonstrating our 
previous conclusions on the absence of detection of any differential band or 
AfpB-like protein in those P. digitatum culture supernatants3. 
Western blot analyses were also performed for the heterologously 
produced PpAfpB* protein with antibodies against PAFB (Fig. 3b, bottom 
panel). Supernatants from P. pastoris pPICZαA-AfpB* containing colonies 
grown under inducing conditions and purified PpAfpB* reacted with the 
antiserum while, as anticipated by Coomassie staining, no protein was detected 
in the non-induced supernatants or in cell lysates. 
 
Mass spectrometry revealed different processing of PAF and AfpB SP-pro 
sequence. Molecular mass of AfpB proteins purified from P. digitatum was also 
determined by matrix-assisted laser desorption/ionization–time-of-flight mass 
spectrometry (MALDI-TOF MS) analysis. Single peaks corresponding to 
average masses of 6570.53 and 6458.01 Da were detected for AfpB and AfpB*, 
respectively (Fig. 4). The experimental mass of AfpB* is consistent with the 
calculated theoretical mass of the oxidized protein predicted after cleavage from 
the PAF SP-pro sequence (6456.23 Da), indicating the presence of three intra-
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molecular disulphide bonds and the absence of other post-translational 
modifications. Interestingly the average mass detected for AfpB revealed the 
presence of an extra leucine residue at the N-terminus end of the protein 
(calculated theoretical mass 6575.39 Da) suggesting a different cleavage of the 
native AfpB SP-pro sequence. 
The MS corresponding to PpAfpB* revealed one main signal of 6455.20 
Da (Supplementary Fig. S3) in accordance with the calculated molecular mass 
of the oxidized protein form and the proper processing of the yeast α-factor SS. 
An additional minor signal of 7104.54 Da that did not correspond to any 
potential variable N-terminus was detected.  
 
Electronic circular dichroism spectroscopy assays revealed incomplete 
refolding capability of the AfpB* variant. Electronic circular dichroism (ECD) 
spectroscopy was used to determine protein conformation and proper folding of 
both P. digitatum AfpB and AfpB* variants. The ECD spectra recorded at 25 °C 
were nearly identical for both variants (Fig. 5 and Supplementay Fig. S4), and 
similar to those recorded for PAF, NFAP19 and other disulphide bridged, β-
structured proteins28. The spectra had two maxima at 195 and 229 nm. The 
maximum at 229 nm was mainly attributed to the presence of disulphide bridges 
while the maximum centred at 195 nm reflected contributions from both β-
pleated conformation and the electronic transitions of disulphide bridges. 
Spectra measured at 95 °C reflected the loss of ordered structure in both AfpB 
variants. After cooling back to 25 °C, the native fold of AfpB was restored 
completely and almost immediately (Fig. 5a). In contrast, a slow structural 
reorganization of AfpB* took place with incomplete refolding even after 72 h (Fig 
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5b). This observation may be attributed to the absence of the leucine residue at 
the N-terminus of this protein variant. 
 
AfpB was highly active against Penicillium species including P. digitatum. 
Both AfpB protein variants, and PAF as an internal control, were tested for their 
antimicrobial activity towards Escherichia coli, Saccharomyces cerevisiae and a 
selection of filamentous fungi that include, in addition to the P. digitatum 
parental strain, several plant pathogens such as the citrus fruit specific 
Penicillium italicum, the main postharvest pathogen of pome fruit P. expansum, 
the polyphagous Botrytis cinerea, the rice blast fungus Magnaporthe oryzae, 
and the soilborne plant pathogen Fusarium oxysporum. The PAF producer 
P. chrysogenum strain, and a strain from Aspergillus niger which is particularly 
sensitive to the PAF protein were also tested. No differences in antimicrobial 
activity were observed among AfpB, AfpB* and PpAfpB* produced in either 
P. digitatum or P. pastoris (Supplementary Fig. S5). Therefore, only results from 
AfpB produced in P. digitatum are shown. AfpB was inactive against E. coli and 
S. cerevisiae at the highest concentration tested (200 µg/ml). AfpB showed 
antifungal activity and inhibited the growth of all fungi tested, with the exception 
of M. oryzae (Fig. 6). The minimum inhibitory concentration (MIC) values varied 
from 1.6 µg/ml in P. italicum to 100 µg/ml in F. oxysporum. The three plant 
pathogenic Penicillium species tested were considerably sensitive to the 
protein, including its producer strain. With the exception of the PAF-sensitive 
A. niger, AfpB showed higher antifungal activity than PAF, with MIC values at 
least one order of magnitude lower. 
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AfpB showed high protease and thermal resistance. The sensitivity of AfpB 
to proteolytic digestion was tested using proteinase K and evaluating the 
residual antifungal activity against P. digitatum. Preincubation of AfpB and 
AfpB* with proteinase K did not decrease the antifungal activity of any of both 
protein variants (Supplementary Fig. S6), pointing out the high protease 
resistance of these antifungal proteins. 
The incomplete refolding of AfpB* found with the ECD analyses allowed 
us to test and determine the effect of heat treatment and folding on the 
antifungal activity. After heat treatment at 95 °C for 5 min and cooling back to 25 
°C (mimicking the ECD conditions) the antifungal activity of both protein variants 
was practically equal and comparable to that observed without treatment 
(Supplementary Fig. S7), suggesting that native AfpB refolding is not necessary 
for its antifungal activity. 
Further experiments were conducted to compare the thermal stability of 
PAF and AfpB. After heat treatment at 80 ºC or 95 °C for 10 and 60 min and 
cooling back to 25 °C, the antifungal activity of PAF and AfpB were tested 
against P. digitatum. Fungal conidia were exposed to twofold MIC 
concentrations of heat-treated proteins (100 µg/ml for PAF, Fig. 7a, and 6.5 
µg/ml for AfpB, Fig. 7b). The antifungal activity of PAF against P. digitatum at 
that concentration resulted in a growth reduction of 70-80% after 10 min of heat 
treatment at 95 ºC and 80 ºC, respectively in comparison with the untreated 
control (>95%). After 60 min of heat treatment, PAF showed a P. digitatum 
growth reduction of 60% at 80 ºC and 55% at 95 ºC. In the same conditions, 
AfpB showed total inhibition of the fungus growth (>95%, comparable to the 
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non-treated control), demonstrating that AfpB is more resistant to heat 
treatment than PAF. 
 
AfpB showed no haemolytic activity against human red blood cells. 
Haemolytic activity assays are performed in order to determine the cytotoxicity 
of specific proteins and peptides against eukaryotic cells by their ability to lyse 
human red blood cells (RBCs)29. In this study, we determined the haemolytic 
activity of both AfpB variants at different concentrations from 1 to 100 μM 
(approximately 200 times the MIC against P. digitatum). In these experiments, 
PAF and melittin from honeybee30 were included as negative and positive 
controls, respectively. Since the haemolytic properties of cationic peptides may 
show ionic strength dependence, haemolytic assays were conducted not only 
with a high ionic strength phosphate NaCl buffer (PBS) but also with a low ionic 
strength isotonic glucose phosphate buffer (PBG)29. 
As expected, the haemolytic peptide melittin caused 100% haemolysis at 
the highest concentration tested and around 80% at 10 μM (Fig. 8). By contrast, 
none of the AFPs showed haemolytic activity at any of the concentrations 
tested, neither in the presence of NaCl as in PBS (Fig. 8a) nor glucose (Fig. 
8b), with values close to the control where no protein was added. 
 
Discussion 
In this study, we described the biotechnological production and 
characterization of AfpB, the only AFP encoded in the phytopathogenic fungus 
P. digitatum. This protein is a new member of AFPs grouped into the class B 
phylogenetic cluster3. For the first time, AfpB was produced, detected and 
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purified from culture supernatants of recombinant P. digitatum and P. pastoris 
strains. The homologous production of AfpB in P. digitatum with the paf-derived 
expression cassette resulted in high yields around 12-20 mg protein/l, whereas 
the heterologous production in P. pastoris resulted in yields 10-fold lower (1.2-
1.4 mg/l). Both approaches allowed one-step purification of fully active AfpB, 
and the purified protein from the two systems showed the same antifungal 
potency. Our results demonstrate that both filamentous fungi and yeasts are 
good production platforms for AFPs. The homologous system appears as the 
most efficient system reaching high yields; whereas the heterologous system 
has the advantage of time reduction since optimal production was achieved 
after 11 days of growth in P. digitatum while only 2 days were needed with the 
P. pastoris system. 
Previously, three other class B AFPs were characterized: Anafp from 
A. niger31, PgAFP from P. chrysogenum32 and MAFP1 from Monascus 
pilosus33. They show an amino acid identity with P. digitatum AfpB of 79, 88, 
and 83%, respectively, much higher than the percentage of identity shared 
between AfpB and the class A PAF from P. chrysogenum, with only 33% 
identity3. The three of them were successfully isolated from the culture 
supernatants of the corresponding native and producer fungus. Notably, the 
concentration of purified PgAFP obtained from P. chrysogenum CECT 20922, 
which was isolated from cured meat, was up to 700 µg/ml32. Also, the class A 
PAF and AFP are secreted in large amounts by P. chrysogenum17 and 
A. giganteus13, respectively. However, previous attempts to detect AfpB in 
P. digitatum culture supernatants failed, even in P. digitatum transformants for 
afpB constitutive expression under the strong gpdA promoter from A. nidulans3. 
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Remarkably, those transformant strains showed a drastic reduction of axenic 
growth, abnormal hyphal morphology and delayed conidiogenesis3. Here, we 
have confirmed with immunodetection that AfpB is not produced by any of the 
previous strains. By contrast, afpB expression under the regulation of the strong 
paf promoter and the corresponding paf terminator warranted the production 
and secretion of the protein at high levels, concomitant with only a moderate 
reduction of axenic growth. We showed that AfpB production is similar in the 
presence of either the paf- or the afpB-specific SP-pro sequences, indicating 
that the impossibility to detect AfpB in either the parental or constitutive strain 
cultures is not due to the native AfpB SP-pro peptide, but to the regulatory 
sequences. The P. chrysogenum paf promoter has been demonstrated to have 
greater efficiency than the A. nidulans gpdA constitutive promoter used as for 
the expression of reporter genes in P.  chrysogenum34, however, the 
approximately 2-fold difference in efficiency cannot account for the absence of 
AfpB accumulation when the gpdA promoter was used. In addition, differences 
in 5’ untranslated regions (UTRs) in the mRNA have been demonstrated to play 
an important role in determining the translation efficiency of proteins in 
filamentous fungi35. Nevertheless, AfpB production was also achieved in the 
P. pastoris expression system under the control of the AOX1 promoter using the 
yeast α-factor SS. Additional studies are required to elucidate the exact 
mechanism underlying the problematic of native afpB translation and protein 
accumulation in P. digitatum. 
In accordance with the antimicrobial profile of native AFPs that possess 
antifungal but not antibacterial activity1,17, AfpB displayed antifungal activity 
against selected filamentous fungi and it was inactive against bacteria (E. coli) 
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or yeast (S. cerevisiae) However, the homologous protein AnAFP from A. niger 
inhibited the proliferation of Candida albicans and S. cerevisiae31 whereas the 
other two class B representatives did not show any effect on different bacteria 
and yeast species32,33. Recently a new AFP from N. fischeri named NFAP2 
proved to be highly effective against targeted yeasts including clinically relevant 
Candida species6. NFAP2, which seems to be the first member of a new, 
phylogenetically distinct fourth group among AFPs, showed MIC values in the 
range of 0.2–1.5 µg/ml. Potential AfpB anti-yeast activity against non-laboratory 
strains and/or pathogenic isolates deserves future research. 
Until this study it was assumed that AFPs are not active against the 
producer fungus, and it has been speculated that fungi possess innate sensing 
or defense systems which enable them to discriminate between AFPs from self 
or non-self origin36. Whether the function of fungal AFPs is mainly defensive or 
associated with fungal growth and development is still controversial. Null 
mutation of the afpB gene in P. digitatum did not affect spore production, growth 
or virulence3, contrarily to that described for the null mutation of the paf gene in 
P. chrysogenum that severely affected asexual development, spore production 
and associated gene regulation37. Recently, novel functions related to nutrient 
recycling during starvation, autophagy, and development for the AnAFP 
produced by A. niger have been proposed36. It is very tempting to speculate that 
AFPs from different classes do have distinct biological functions in the producer 
fungus and also distinct mechanisms of antifungal action. This seems to be the 
case in the AfpB/PAF couple, according to the different phenotypes of the 
corresponding null mutants but also to the different activity profiles of both 
proteins against P. digitatum, P. expansum or A. niger. 
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AfpB is highly active against the own producer P. digitatum strain when 
added exogenously to the culture media (MIC = 3.2 µg/ml; Fig. 6), which is not 
the case of PAF against P. chrysogenum (MIC > 200 µg/ml). However, the 
fungal strain engineered to express the afpB gene produces high amounts of 
AfpB without deleterious effect to the axenic growth or pathogenicity of 
P. digitatum. This fungus is also susceptible to PAF protein (MIC = 50 µg/ml) 
but P. digitatum engineered strains were also able to produce PAF in high 
quantities19. In contrast, the heterologous expression of the nfap gene in a 
NFAP-sensitive A. nidulans strain only permitted the production of low amounts 
of protein (approximately 1.7 mg/l), but it provoked reduced hyphal growth and 
delayed and abnormal germination38. Other fungal AFPs such as AnAFP and 
A. giganteous AFP have been described as only moderate-active towards the 
producer strains36 whereas the class B PgAFP was not active against its 
producing strain P. chrysogenum CECT 20922 while it showed antifungal 
activity against another P. chrysogenum strain, pointing out strain-dependent 
activity32. 
AfpB is unique for its very high antifungal activity against filamentous 
fungi that include the fungus from which the gene was identified. Our side-by-
side experiments demonstrate that AfpB has higher levels of antifungal efficacy 
when compared to PAF (Fig. 6). With respect to other class B proteins already 
characterized, AnAfpB showed similar antifungal activity against 
F. oxysporum31, and PgAfpB was as well active against other P. expansum and 
A. niger strains32. The activity of AfpB against the Penicillium species tested 
deserves to be emphasized. All of them were highly sensitive to AfpB: MIC 
values in the range of 1.6-6.25 µg/ml that is equivalent to 0.25-1 µM. 
18 
 
Remarkably, current fruit losses due to Penicillium decay are very important in 
agriculture since Penicillium species reproduce very rapidly and their spores are 
ubiquitous in the atmosphere, facilitating the dissemination on fruit surfaces. 
P. digitatum and P. italicum are the main causal agents of the citrus green and 
blue mold diseases, respectively10. On the other hand, P. expansum, the causal 
agent of the blue mold disease, is one of the most important pathogens of pome 
fruits, causing serious crop losses worldwide11. Unfortunately, there are only a 
few drugs available for the effective treating of fungal infections, and the 
development of resistance against fungicides used in agriculture is increasingly 
alarming. Thus, the use of AfpB as a powerful alternative in the control of 
pathogenic fungi could be of further interest.  
In a previous work, we identified two cysteine-containing cationic 
peptides, PAF112 and PAF118, derived from two surface-exposed loops in 
AfpB, with moderate antifungal activity against P. digitatum with a MIC value of 
64 µM22. Now our results show that AfpB is about 100 times more active than 
the peptides derived from its sequence suggesting that additional 
motifs/sequences in the protein are required to achieve full activity.  
 As generally described for fungal AFPs16, AfpB showed a remarkable 
ability to withstand protease and thermal degradation. It has been assumed that 
the compact tertiary structure stabilized by disulphide bridges of AFPs favours 
protein stability. Although the tertiary structure of AfpB has not yet been 
determined, the predicted AfpB structure by in silico modelling showed a similar 
tertiary structure to those reported for A. giganteous AFP12 and P. chrysogenum 
PAF16,39. In the present study ECD spectroscopic measurements, consistent 
with the previous modelling, suggested the presence of disulphide bridges and 
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a β-pleated conformation, and proved that both AfpB variants have the same 
structural elements as other fungal AFPs19,24. Our data also demonstrate that 
the lack of the leucine residue at the N-terminal end of AfpB* does not affect 
neither the antifungal activity nor the protease and thermal tolerance, although 
this protein variant showed incomplete refolding in the conditions tested. 
Moreover, the demonstration that the heat treatment which denatures AfpB*, 
mostly irreversibly, does not impair antifungal efficacy indicates that protein 
folding is not critical for the antifungal activity. 
Finally, our results suggest that AfpB can be preliminary regarded as 
safe since it did not show haemolytic activity against human RBCs even in 
assays conducted at low ionic strength isotonic conditions, which are 
considered more sensitive for detecting the haemolytic activity of cationic 
peptides29. 
 In summary, this study identifies AfpB from P. digitatum as a highly active 
antifungal protein against filamentous fungi, including the own producer fungus. 
This new member of class B AFPs was produced for the first time in two 
eukaryotic cell factories, the fungus P. digitatum and the yeast P. pastoris. Both 
expression systems allowed proper protein folding, efficient production and 
single-step purification from culture supernatants. The remarkable stability, 
absence of haemolytic activity and high levels of antifungal efficacy against 
filamentous fungi, especially Penicillium species, suggest the potential use of 
AfpB as an antifungal agent. 
 
Methods 
Strains, media and culture conditions 
20 
 
The parental isolate P. digitatum CECT 20796 (PHI26)10 and all of the 
transformants were cultured on PDA plates for 7-10 days at 25 ºC. To analyse 
the growth on solid medium, 5 µl of conidial suspension (5 × 104 conidia/ml) 
were deposited on the centre of PDA and PdMM plates19, and the diameter of 
growth was monitored daily from 3 to 10 days. For AfpB production, strains 
were inoculated at a concentration of 106 conidia/ml in 500 ml of PdMM and 
incubated at 25 ºC with shaking for 14 days. For the antimicrobial assays, 
B. cinerea CECT 2100, F. oxysporum 4287, P. expansum CMP1, P. italicum 
CECT 2294, P. chrysogenum Q176, and M. oryzae PR9 were incubated at 
25 ºC, E. coli JM109 and A. niger CBS 120.49 at 37 ºC, and S. cerevisiae 
BY4741 at 30 ºC. For the fungal transformation, vectors were propagated in E. 
coli JM109 grown in Luria Bertani (LB) medium supplemented with 100 µg/ml 
ampicillin or 75 µg/ml kanamycin. Agrobacterium tumefaciens AGL-1 strain was 
grown in LB supplemented with 20 µg/ml rifampicin at 28 ºC. P. pastoris X-33 
wild-type strain was cultured on yeast extract peptone dextrose (YPD) medium 
at 28 ºC. 
 
Generation of the P. digitatum AfpB producer strains 
To generate the P. digitatum AfpB producer strains, two different genetic 
approaches were performed. The first approach included the full-length AfpB 
coding sequence (afpB) cloned under the control of the paf gene promoter and 
terminator sequences from P. chrysogenum. The second approach included the 
in silico predicted mature AfpB coding sequence3 (afpB*) cloned under the 
control of the paf gene promoter, paf SP-pro sequence and the paf gene 
terminator (Fig. 1a). The specific primers used to generate the P. digitatum 
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AfpB producer strains are described in Supplementary Table S1 and 
Supplementary Fig. S1a. The afpB gene was amplified from P. digitatum 
CECT 20796 genomic DNA, while the paf gene promoter, SP-pro and 
terminator sequences were generated by PCR amplification of the fragments 
from the vector pSK275paf19. PCR reactions were performed using AccuPrime 
High-Fidelity polymerase (Invitrogen) and the constructs verified by Sanger 
DNA sequencing. The two different DNA constructions were generated by 
Fusion PCR40 and cloned into the pGEM-T® Easy vector system (Promega) 
from where they were excised with XmaI and XbaI and inserted into the 
digested binary vector pBHt241 containing the hygromycin resistant cassette 
(hph) used as positive selection marker. The binary vectors were transformed 
into A. tumefaciens AGL-1, and the fungal transformation of P. digitatum 
parental strain was performed by A. tumefaciens-mediated transformation 
(ATMT)41,42. Positive transformants were confirmed by PCR amplification of 
genomic DNA43 (Supplementary Fig. S1; Supplementary Table S1). 
 
Generation of the P. pastoris AfpB producer strains 
To generate the P. pastoris AfpB producer strain, the P. digitatum cDNA 
encoding the predicted AfpB protein sequence (afpB*) was obtained as 
previously described43 and amplified by PCR using the primers MO3 and MO4 
(Supplementary Table S1). The afpB* cDNA sequence was inserted into the 
XhoI and XbaI digested pPICZαA plasmid (Invitrogen) carrying AOX1 promoter 
for methanol-induced expression of afpB* in P. pastoris. The afpB* cDNA was 
inserted in frame with a modified version of the yeast α-factor SS, lacking the 
Ste13 cleavage sites, but including the Kex2 signal cleavage site (Fig. 1b). 
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Constructs were verified by Sanger DNA sequencing. The digested plasmid 
pPICZαA-afpB with AvrII was used to transform P. pastoris X-33 cells by 
electroporation. After 5 min of incubation at 4 ºC, cells were subjected to a 
pulse (1.5 kV, 200 Ω) in 0.2-cm cuvettes and were immediately diluted with 1 ml 
of ice-cold 1M sorbitol and plated on YPD medium containing 1M sorbitol and 
100 µg/ml zeocin. Plates were incubated for 3-4 days at 28 ºC. Two 
independent colonies were selected (#1 and #3) and used for PpAfpB* 
production. Transformant cells were grown in buffered minimal glycerol medium 
BMG (0.1 M potassium phosphate buffer, pH 6; 1.34% yeast nitrogen base; 4 x 
10-5% biotin; 1% glycerol), and transferred to BMM (buffered minimal medium 
with 0.5% methanol instead of glycerol as carbon source) for afpB* induction. 
 
Protein production and purification  
AfpB variants were purified from the supernatants of P. digitatum 
transformant strains (AfpB and AfpB*) and P. pastoris positive transformants 
(PpAfpB*). Cell-free supernatants of P. digitatum grown on PdMM for 11 days 
or P. pastoris grown on BMM for 2 days were collected by centrifugation and 
dialyzed (2 K MWCO,) against 20 mM phosphate buffer pH 6.6. Dialyzed 
solutions were applied to an AKTA Purifier system equipped with a 6 ml 
RESOURCE S column (GE Healthcare) for P. digitatum supernatants or a 5 ml 
HiTrap SP HP column (GE Healthcare) for P. pastoris supernatants, 
equilibrated in phosphate buffer. Proteins were eluted with a linear NaCl 
gradient from 0 to 0.5 M in the same buffer. 
Protein containing fractions were pooled, dialyzed against Milli-Q water 
and lyophilized. Protein concentrations were determined spectrophotometrically 
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(A280) considering the molar extinction coefficient (Ɛ280 = 0.52). Purification was 
monitored by SDS-PAGE44 using SDS-16% polyacrylamide gels calibrated with 
prestained protein size-standard SeeBlue® (ThermoFischer Scientific) or 
Precision Plus Protein Standards (Bio-Rad) and Coomassie stained.  
 
Western blot 
Total proteins from supernatants, lysates and purified AfpB variants were 
separated by SDS-16% polyacrylamide gels and transferred to Amersham 
Protran 0.20 µm NC nitrocellulose transfer membrane (GE Healthcare). Protein 
detection was accomplished using anti-PAFB (unpublished) and anti-PAF27 
antibodies diluted 1:1000 and 1:2000, respectively. As secondary antibody, ECL 
NA934 horseradish peroxidase donkey anti-rabbit (GE Healthcare) was used 
and chemiluminescent detection was performed with ECL™ Select Western 
blotting detection reagent (GE Healthcare) using a LAS-1000 instrument 
(Fujifilm). The experiments were repeated twice. 
 
MALDI-TOF MS 
The mass of the purified proteins was analysed on a 5800 MALDI 
TOF/TOF (AB Sciex) in positive linear mode (1500 shots every position) in a 
range of 2000-20000 m/z. The analysis was carried out in the proteomics facility 
of SCSIE University of Valencia (Spain). 
 
ECD spectroscopy 
ECD spectroscopic measurements were performed in the 185-260 nm 
wavelength range (far–UV) to determine the secondary structure and examine 
24 
 
the structural stability of the two AfpB variants. Protein samples were dissolved 
in pure H2O at approximately 0.1 mg/ml concentration and measured in a 0.1 
cm path-length quartz cuvette19. The spectra are accumulations of 10 scans, 
from which the similarly recorded spectrum of H2O was subtracted. Ellipticity 
data were given in mdeg units. 
 
Protein stability assays 
To investigate thermal stability, proteins (400 µg/ml) were dissolved in 10 
mM 3-(N-morpholino)-propanesulfonic acid (MOPS) pH 7 and were incubated at 
80 ºC and 95 ºC for 5, 10 and 60 min. Proteins were cooled back to 25 ºC and 
directly used to determine the residual antifungal activity. 
Proteolytic digestion assays were performed as previously described45 
with some modifications. Briefly, proteins (400 µg/ml) were dissolved in 10 mM 
MOPS pH 7 and digested with 100 µg/ml of recombinant proteinase K (2 U/mg; 
Sigma-Aldrich) at 30 ºC with shaking. Aliquots were withdrawn at 20 h of 
incubation and immediately heated at 80 ºC for 10 min. Treated proteins were 
used to perform antifungal activity assays. 
 
Antimicrobial activity assays 
Growth inhibition assays were performed in 96-well, flat-bottom microtiter 
plates in a total volume of 100 µl. Fifty µl of fungal conidia (5 × 104 conidia/ml) in 
1/10 diluted potato dextrose broth (PDB) containing 0.02 % (w/v) 
chloramphenicol were mixed in each well with 50 µl of twofold concentrated 
protein from serial twofold dilutions (final concentrations from 0.2-200 µg/ml). 
Samples were prepared in triplicate. Plates were statically incubated for 96 h at 
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25 ºC. Growth was determined every 24 h by measuring the optical density 
(OD) at 600 nm using a Fluostar Omega plate spectrophotometer (BMG 
labtech), and the OD600 mean and standard deviation (s.d.) were calculated. 
Dose-response curves were generated from measurements after 72 h. These 
experiments were repeated at least twice. MIC is defined as the protein 
concentration that completely inhibited growth in all the experiments conducted.  
 
Haemolytic assays 
The haemolytic activity of the proteins was determined in a 96 round-
bottom microtiter plate on human 1:40 diluted RBCs as previously described29,46 
with some modifications. Briefly, RBCs were harvested by centrifugation for 15 
min at 100 × g and washed three times in 35 mM PBS (pH 7, 150 mM NaCl) or 
PBG (250 mM glucose as osmoprotectant). One hundred µl of twofold protein 
concentration were mixed with 100 µl of RBCs in triplicate. Plates were 
incubated for 1 h at 37 ºC and centrifuged for 5 min at 300 × g. Supernatants 
(100 µl) were transferred to a new microtiter plate and the absorbance was 
measured at 415 nm. 
No haemolysis and 100% haemolysis were determined in controls with a 
mixture of PBS or PBG, and 0.1% Triton X-100, respectively. The haemolytic 
activity was calculated as the percentage of total haemoglobin released 
compared with that released by incubation with 0.1% Triton X-100. 
 
Fruit infection assays 
The inoculation of P. digitatum strains on non-treated freshly harvested orange 
fruits (Citrus sinensis L. Osbeck cv Navelina) was conducted as previously 
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described47. Briefly, three replicates of five fruits were inoculated with 5 µl of 
conidial suspension (5 × 104 conidia/ml) at four wounds around the equator. 
Orange fruits were stored at 20 ºC and 90% relative humidity. Each wound was 
scored daily for infection symptoms on consecutive post inoculation days. 
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Figure legends 
 
Figure 1. Schematic representation of the expression systems used to obtain 
AfpB producer strains. a) The PAF diagram constitutes the schematic 
representation of the P. chrysogenum-based expression cassette; in blue: paf 
promoter (Ppaf), paf gene including the paf SP-pro sequence (paf SP), and paf 
terminator (Tpaf). Amino acids involved in the SP-pro peptide cleavage are 
coloured in blue. The AfpB diagram represents the genetic construction with the 
full-length AfpB coding sequence (in red) cloned under the control of the Ppaf 
and Tpaf sequences (in blue). Amino acids involved in the predicted SP-pro 
peptide cleavage are in red. The AfpB* diagram corresponds to the genetic 
construction with the in silico predicted AfpB coding sequence (afpB*) cloned 
under the control of the Ppaf, paf SP-pro sequence and Tpaf. b) The PpAfpB* 
diagram represents the construction with the in silico predicted AfpB coding 
sequence (afpB*, in red) cloned under the control of the AOX1 promoter for 
methanol-induced expression and terminator sequences (in black) and yeast α-
factor signal sequence (α-factor SS) (in green).  
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Figure 2. Growth of P. digitatum AfpB, AfpB* and PAF producer strains. a) 
Colony morphology after 7 days of growth in PDA plates. b) Growth on solid 
PDA and PdMM determined by the colony diameter from 3 to 10 days of growth 
at 25 ºC. Plotted data are mean values ± s.d. of triplicate samples. The strains 
shown are the parental CECT 20796 (isolate PHI26) (black), the AfpB producer 
strains PDSG2441 (AfpB; blue) and PDSG3543 (AfpB*; orange), and the PAF 
producer strain PDSG1521 (purple). 
 
Figure 3. Analyses of supernatants of AfpB-producing strains and purified 
proteins by SDS-PAGE and Western blot. a) P. digitatum supernatants (4-8 ug 
of total protein loaded per lane) and purified proteins (1 µg loaded per lane) 
visualized by Coomassie blue staining (top panel); M: SeeBlue® Pre-Stained 
Protein Standard, supernatants of wild type strain CECT 20796, deletion strain 
PDMG122 ∆afpB, constitutive expression strain PDMG152 afpBc, AfpB 
producer strain PDSG2441, AfpB* producer strain PDSG3543 and PAF 
producer strain PDSG1521. Immunoblot analyses of samples described above, 
using anti-PAFB (middle panel) and anti-PAF (bottom panel) antibodies. b) 
P. pastoris supernatants (15 µg loaded per lane), cell lysates (50 µg loaded per 
lane) and purified proteins (1 µg loaded per lane) visualized by Coomassie blue 
staining (top panel). M: Precision Plus Protein Standard; AfpB*#1 and AfpB*#3: 
selected PpAfpB* producer colonies; Ev: control strain transformed with empty 
vector pPICZαA. S: supernatant; L: cell lysate; under non-induced conditions (-) 
or induced conditions (+). Immunoblot analyses of samples were performed as 
described above using anti-PAFB antibodies (bottom panel).  
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Figure 4. MALDI-TOF MS analyses. Data showing the isotopic average 
molecular mass (m/z) of the two recombinant protein variants AfpB* (red) and 
AfpB (black) produced in P. digitatum. The difference in the molecular mass fits 
with the extra leucine residue present at the N-terminus of the native protein 
AfpB. 
 
Figure 5. ECD spectra of the two recombinant protein variants produced in 
P. digitatum. a) AfpB, and b) AfpB* recorded at 25 °C (green), 95 °C (red), and 
at 25 °C immediately (blue), and 72 h (orange) after cooling from 95 °C to 
25 °C. 
 
Figure 6. In vitro inhibitory activity of AfpB and PAF against filamentous fungi. 
a) Dose-response curves comparing the antifungal activity of PAF (purple 
circles) and AfpB (blue diamonds) against P. digitatum, P. expansum, A. niger, 
and B. cinerea. Dose-response curves show mean ± s.d. OD600 of triplicate 
samples after 72 h of static incubation at 25 °C, except for A. niger, which was 
incubated at 37 ºC. b) MIC values (µg/ml) of AfpB and PAF against all the fungi 
tested. 
 
Figure 7. Effect of heat treatment on the antifungal activity of PAF and AfpB. 
PAF (a) and AfpB (b) (100 and 6.5 µg/ml, respectively) were exposed to 80 and 
95 °C for 10 and 60 min, respectively. Values represent the percentage of 
growth (%) of P. digitatum in the presence of non-treated and treated protein 
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compared to P. digitatum in the absence of protein (control, C). Data show 
mean ± s.d. OD600 of triplicate samples. 
 
Figure 8. Haemolytic activity of the two AfpB variants and PAF. Analyses were 
conducted in PBS (150 mM NaCl) (a), and in PBG (250 mM glucose) (b). 
Proteins were used at the concentrations indicated (from 1 to 100 µM). The 
cytolitic peptide melittin was included for comparison. The haemolytic activity is 
given as the mean ± s.d. of the percentage of human RBCs haemolysis (three 
replicates), as compared with the positive control in the presence of the 
detergent Triton X-100 (regarded as 100% haemolysis). 
 
 








